Dumfriesshire MSP Elaine Murray has welcomed the announcement by the Scottish Medicines Consortium (SMC)that the Lemtrada (alemtuzumab), a treatment for relapsing remitting Multiple Sclerosis, has now been accepted as a treatment which can be offered by the NHS in Scotland.
Elaine Murray said:
“The English equivalent of the SMC, the National Institute for Health and Care Excellence (NICE) had already recommended that Lemtrada should be prescribed on the NHS and that from September 2014, hospitals and NHS Trusts in England and Wales will have to prescribe Lemtrada to all people who are eligible for it and who choose to take it.
“A constituent whose daughter suffers from MS had drawn to my attention the fact that no such announcement had been made in Scotland, therefore I contacted the Scottish Government to enquire when a decision be made in Scotland.
There have been other occasions when drugs available on the NHS in England and Wales have not been available here in Scotland. I am pleased that MS sufferers in my constituency and across Scotland who may benefit from this treatment will now be able to access it on prescription”.